Cargando…
Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431390/ https://www.ncbi.nlm.nih.gov/pubmed/37601460 http://dx.doi.org/10.1097/AS9.0000000000000288 |
_version_ | 1785091189404336128 |
---|---|
author | Riou, Olivier Gourgou, Sophie Conroy, Thierry |
author_facet | Riou, Olivier Gourgou, Sophie Conroy, Thierry |
author_sort | Riou, Olivier |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer Health, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104313902023-08-18 Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint Riou, Olivier Gourgou, Sophie Conroy, Thierry Ann Surg Open Letter to the Editor Wolters Kluwer Health, Inc. 2023-06-02 /pmc/articles/PMC10431390/ /pubmed/37601460 http://dx.doi.org/10.1097/AS9.0000000000000288 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Letter to the Editor Riou, Olivier Gourgou, Sophie Conroy, Thierry Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint |
title | Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint |
title_full | Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint |
title_fullStr | Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint |
title_full_unstemmed | Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint |
title_short | Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint |
title_sort | comment on “locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared to long-course chemoradiotherapy and surgery: a five-year follow-up of the rapido trial”: the rapido trial does not achieve its primary endpoint |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431390/ https://www.ncbi.nlm.nih.gov/pubmed/37601460 http://dx.doi.org/10.1097/AS9.0000000000000288 |
work_keys_str_mv | AT riouolivier commentonlocoregionalfailureduringandaftershortcourseradiotherapyfollowedbychemotherapyandsurgerycomparedtolongcoursechemoradiotherapyandsurgeryafiveyearfollowupoftherapidotrialtherapidotrialdoesnotachieveitsprimaryendpoint AT gourgousophie commentonlocoregionalfailureduringandaftershortcourseradiotherapyfollowedbychemotherapyandsurgerycomparedtolongcoursechemoradiotherapyandsurgeryafiveyearfollowupoftherapidotrialtherapidotrialdoesnotachieveitsprimaryendpoint AT conroythierry commentonlocoregionalfailureduringandaftershortcourseradiotherapyfollowedbychemotherapyandsurgerycomparedtolongcoursechemoradiotherapyandsurgeryafiveyearfollowupoftherapidotrialtherapidotrialdoesnotachieveitsprimaryendpoint |